CSTI-200

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCSTI-200
Drug Alias NameCSTI-200
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycine transporter 1 inhibitors
TargetsGlycine transporter 1
Therapy Area/IndicationsCognition DisordersPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlbany Molecular Research Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesConsynance TherapeuticsAlbany Molecular Research Inc
Active IndicationsN/A
Inactive IndicationsCognition DisordersPain

Other Information

ATC CodeN/A
Related LinksN/A